These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10353255)

  • 1. Sensitivity of L-(-)2,3-dideoxythiacytidine resistant hepatitis B virus to other antiviral nucleoside analogues.
    Fu L; Liu SH; Cheng YC
    Biochem Pharmacol; 1999 Jun; 57(12):1351-9. PubMed ID: 10353255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibilities of wild-type or drug-resistant hepatitis B virus to (-)-beta-D-2,6-diaminopurine dioxolane and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil.
    Chin R; Shaw T; Torresi J; Sozzi V; Trautwein C; Bock T; Manns M; Isom H; Furman P; Locarnini S
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2495-501. PubMed ID: 11502520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of novel human hepatoma cell lines with stable hepatitis B virus secretion for evaluating new compounds against lamivudine- and penciclovir-resistant virus.
    Fu L; Cheng YC
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3402-7. PubMed ID: 11083647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-hepatitis B virus activity and metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine.
    Zhu YL; Dutschman DE; Liu SH; Bridges EG; Cheng YC
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1805-10. PubMed ID: 9661025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse transcriptase activity of hepatitis B virus (HBV) DNA polymerase within core capsid: interaction with deoxynucleoside triphosphates and anti-HBV L-deoxynucleoside analog triphosphates.
    Lam W; Li Y; Liou JY; Dutschman GE; Cheng YC
    Mol Pharmacol; 2004 Feb; 65(2):400-6. PubMed ID: 14742682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, L-FMAU, DAPD, penciclovir and lobucavir.
    Ying C; De Clercq E; Nicholson W; Furman P; Neyts J
    J Viral Hepat; 2000 Mar; 7(2):161-5. PubMed ID: 10760047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC).
    Das K; Xiong X; Yang H; Westland CE; Gibbs CS; Sarafianos SG; Arnold E
    J Virol; 2001 May; 75(10):4771-9. PubMed ID: 11312349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
    Andrei G; De Clercq E; Snoeck R
    Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
    Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
    Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of additional mutations outside the YMDD motif of hepatitis B virus polymerase in L(-)SddC (3TC) resistance.
    Fu L; Cheng YC
    Biochem Pharmacol; 1998 May; 55(10):1567-72. PubMed ID: 9633992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antihepadnaviral activities of combinations of penciclovir, lamivudine, and adefovir.
    Colledge D; Civitico G; Locarnini S; Shaw T
    Antimicrob Agents Chemother; 2000 Mar; 44(3):551-60. PubMed ID: 10681317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening.
    Walters KA; Tipples GA; Allen MI; Condreay LD; Addison WR; Tyrrell L
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1936-42. PubMed ID: 12760870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir.
    Brunelle MN; Jacquard AC; Pichoud C; Durantel D; Carrouée-Durantel S; Villeneuve JP; Trépo C; Zoulim F
    Hepatology; 2005 Jun; 41(6):1391-8. PubMed ID: 15915463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors.
    Ono-Nita SK; Kato N; Shiratori Y; Lan KH; Yoshida H; Carrilho FJ; Omata M
    J Clin Invest; 1999 Jun; 103(12):1635-40. PubMed ID: 10377169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation pattern emerging during lamivudine treatment shows cross-resistance to adefovir dipivoxil treatment.
    Karatayli E; Karayalçin S; Karaaslan H; Kayhan H; Türkyilmaz AR; Sahin F; Yurdaydin C; Bozdayi AM
    Antivir Ther; 2007; 12(5):761-8. PubMed ID: 17713159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-resistance testing of antihepadnaviral compounds using novel recombinant baculoviruses which encode drug-resistant strains of hepatitis B virus.
    Delaney WE; Edwards R; Colledge D; Shaw T; Torresi J; Miller TG; Isom HC; Bock CT; Manns MP; Trautwein C; Locarnini S
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1705-13. PubMed ID: 11353615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation into drug-resistant mutations of HBV from 845 nucleoside/nucleotide analogue-naive Chinese patients with chronic HBV infection.
    Li X; Liu Y; Zhao P; Wang Y; Chen L; Xin S; Zhang XX; Xu D
    Antivir Ther; 2015; 20(2):141-7. PubMed ID: 24992206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
    Delaney WE; Locarnini S; Shaw T
    Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory activity of dioxolane purine analogs on wild-type and lamivudine-resistant mutants of hepadnaviruses.
    Seignères B; Pichoud C; Martin P; Furman P; Trépo C; Zoulim F
    Hepatology; 2002 Sep; 36(3):710-22. PubMed ID: 12198665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential use of antiviral L(-)nucleoside analogues for the prevention or treatment of viral associated cancers.
    Cheng YC
    Cancer Lett; 2001 Jan; 162 Suppl():S33-S37. PubMed ID: 11164188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.